TD Cowen Upgrades RXO to Hold, Raises Price Target to $30.25

Benzinga · 5d ago
TD Cowen analyst Jason Seidl upgrades RXO (NYSE:RXO) from Sell to Hold and raises the price target from $17.5 to $30.25.